ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
68 766,01
-0,73%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Precision BioSciences Inc (DTIL)

  7. Precision BioSciences Inc (DTIL) Actualités

DTIL Precision BioSciences Inc

12,74
-0,26 (-2,00%)
25 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Precision BioSciences Inc DTIL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,26 -2,00% 12,74 06:00:07
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
12,97 12,4016 13,207 12,74 13,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/5/202413:00BWPrecision BioSciences Announces Grant of Inducement Awards..
13/5/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202413:15EDGAR2Form 8-K - Current report
13/5/202413:00BWPrecision BioSciences Reports First Quarter 2024 Financial..
09/5/202402:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202402:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202402:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202402:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202414:19EDGAR2Form 8-K - Current report
08/5/202414:15BWPrecision BioSciences Announces Common Stock Purchase by..
07/5/202422:30BWPrecision BioSciences to Report First Quarter Results on May..
07/5/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202414:30BWPrecision BioSciences Announces Receipt of FDA Fast Track..
01/5/202413:05BWPrecision BioSciences Announces Late-Breaking Poster..
16/4/202422:15BWPrecision BioSciences Announces Return of Programs and..
27/3/202411:45BWPrecision BioSciences Reports Fourth Quarter and Fiscal Year..
20/3/202421:30BWPrecision BioSciences to Report Fourth Quarter and Fiscal..
19/3/202412:00BWPrecision BioSciences Presents Preclinical Data Highlighting..
06/3/202414:45BWPrecision BioSciences Announces MHRA Approval for Partner..
01/3/202414:00EDGAR2Form 8-K - Current report
01/3/202412:30BWPrecision BioSciences Announces $40.0 Million Offering of..
01/3/202412:00EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
29/2/202423:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202422:01BWPrecision BioSciences Announces Proposed Public Offering of..
20/2/202413:00BWPrecision BioSciences Announces Non-Exclusive Patent License..
14/2/202413:00BWPrecision BioSciences Receives Pre-IND Feedback from US FDA..
13/2/202414:29EDGAR2Form 8-K - Current report
13/2/202413:00BWPrecision BioSciences Promotes Naresh Tanna to Vice..
12/2/202417:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202413:00BWPrecision BioSciences Receives Initial $7.5 Million Cash..
09/2/202413:00BWPrecision BioSciences to Effect a Reverse Stock Split
24/1/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:29EDGAR2Form 8-K - Current report
23/1/202422:27EDGAR2Form 144 - Report of proposed sale of securities
22/1/202421:46EDGAR2Form 144 - Report of proposed sale of securities
22/1/202421:42EDGAR2Form 144 - Report of proposed sale of securities
22/1/202421:42EDGAR2Form 144 - Report of proposed sale of securities
19/1/202413:30EDGAR2Form 8-K - Current report
12/1/202414:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/1/202414:31EDGAR2Form 8-K - Current report
09/1/202415:20APSBiotech Massively Bid Up Before Opening Bell

Dernières Valeurs Consultées

NASDAQ
DTIL
Precision BioSciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés